Listed by the USPTO as NORTH, ISABELLA SARAH HYO SO
Tech Center 3700 • Art Units: 3783
This examiner grants 64% of resolved cases
NORTH, ISABELLA SARAH HYO SO has resolved 33 cases in Tech Center 3700 and Art Unit 3783. The allowance rate is 63.6%, with a median of 1357 days to allowance. The interview lift is 15.0%, which supports considering interviews as one part of a prosecution plan when applicants need to clarify claim scope or address outstanding issues.
The companies most frequently represented are Becton, Dickinson and Company, Becton Dickinson France, and Ypsomed AG. Frequently appearing firms are DORSEY & WHITNEY LLP - Minneapolis, BakerHostetler, and Bond, Schoeneck & King, PLLC - SANOFI. Because the record covers 33 resolved cases, counsel should pair this profile with the facts of the individual application.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18098632 | Catheter Insertion System | Non-Final OA | Bard Access Systems, Inc. |
| 17782003 | AN INJECTION DEVICE FOR DELIVERING A LIQUID DRUG | Non-Final OA | Novo Nordisk A/S |
| 17764504 | AIR ELIMINATION ASSEMBLIES | Non-Final OA | CareFusion 303, Inc. |
| 17774010 | CATHETER TUBE FOR A STEERABLE CATHETER, AND METHOD FOR IMPLANTING AN IMPLANTABLE MEDICAL DEVICE BY MEANS OF A STEERABLE CATHETER | Non-Final OA | BIOTRONIK SE & Co. KG |
| 17761059 | Systems and Methods for Opening Eustachian Tubes | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 19328603 | CODE AND CODE READER ARRANGEMENT FOR AN INJECTION DEVICE | Non-Final OA | Ypsomed AG |
| 19314461 | A NEEDLE SHIELD REMOVER | Non-Final OA | Ypsomed AG |
| 18157394 | METHODS AND SYSTEMS FOR PRESSURE-BASED FLUID CONTROL IN A FLUID DELIVERY SYSTEM | Final Rejection | INSULET CORPORATION |
| 18704861 | AUTOINJECTOR | Non-Final OA | medmix Switzerland AG |
| 18594723 | CATHETER ASSEMBLY WITH MICRO-TEXTURED SURFACE AND METHOD OF MANUFACTURE | Non-Final OA | Becton, Dickinson and Company |
| 17859627 | System and Method for Pressure Sensor Based Gas Bubble Detection for a Drug Delivery Device | Final Rejection | Becton, Dickinson and Company |
| 17743941 | Catheter Assembly and Related Devices and Methods | Non-Final OA | Becton, Dickinson and Company |
| 17692997 | COMPOSITIONS AND METHODS FOR USING ALTERNATING ELECTRIC FIELDS TO DISRUPT NANOPARTICLES | Final Rejection | NOVOCURE GMBH |
| 18003643 | NEEDLELESS INJECTOR | Non-Final OA | DAICEL CORPORATION |
| 18718749 | ASSEMBLY FOR AN INJECTION DEVICE, INJECTION DEVICE COMPRISING SUCH AN ASSEMBLY, MEDICAMENT CONTAINER FOR SUCH AN ASSEMBLY, AND METHOD FOR PRODUCING SUCH A MEDICAMENT CONTAINER | Non-Final OA | Sanofi |
| 17914484 | Electronic System for a Drug Delivery Device | Final Rejection | Sanofi |
| 17798649 | LOCKING MECHANISM FOR A MEDICAMENT DELIVERY DEVICE | Final Rejection | SHL MEDICAL AG |
| 17774267 | MEDICAMENT DELIVERY DEVICE | Non-Final OA | SHL MEDICAL AG |
| 17793046 | MEDICAL DEVICE WITH SAFETY VERIFICATION AND SAFETY VERIFICATION METHOD THEREOF | Non-Final OA | MEDTRUM TECHNOLOGIES INC. |
| 18006269 | INFUSION APPARATUS | Final Rejection | TESSEN SOLUTIONS LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy63.6% of resolved applications examined by Isabella Sarah Hyo So North were allowed (33 resolved cases), compared with 67.2% across Art Unit 3783 over the last five years.
This examiner's interview lift is +15.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Isabella Sarah Hyo So North took 1,357 days on average from filing to allowance.
Isabella Sarah Hyo So North examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).